APC and colorectal cancer: More than 90% of colorectal cancers have activating somatic mutations in the WNT pathway (APC loss or β-catenin mutation), thus the WNT pathway activation is considered as a prerequisite for colorectal cancer pathogenesis (29, 80–86).